# NTCP ubiquitination enables HBV infection

## TL;DR

This study shows that ubiquitination of the NTCP protein at position K340 is essential for the internalization of HBV into liver cells, offering a potential new way to block HBV infection.

## Contribution

The study identifies K340 as the main ubiquitination site in NTCP and demonstrates its role in HBV internalization.

## Key findings

- NTCP ubiquitination at K340 is crucial for HBV entry into hepatocytes.
- Inhibiting ubiquitination reduces HBV infection and impairs NTCP endocytosis.
- Mutating K340 to arginine increases NTCP membrane abundance but decreases HBV infectivity.

## Abstract

The sodium taurocholate cotransporting polypeptide (NTCP), the main hepatic uptake transporter of bile salts, is the docking receptor required for the HBV/HDV entry. However, the mechanism of NTCP-dependent internalization of HBV/HDV into hepatocytes is unclear. Thus, we investigated the contribution of post-translational modification of NTCP to transporter endocytosis and HBV infection.

NTCP ubiquitination was determined by immunoprecipitation of wild-type NTCP (NTCPWT). Lysine (K) residues in the C terminus were substituted by arginine (R) to identify ubiquitination sites. HepG2 cells overexpressing NTCP mutants were analyzed for protein levels, bile salt uptake activity, NTCP endocytosis, and HBV infectivity. The global ubiquitination inhibitor TAK-243 was used to study effects on uptake and HBV infection in NTCPWT-HepG2 and HepaRG cells. Sample sizes in the experiments were 3–10.

NTCP was found to be ubiquitinated. Compared with NTCPWT, the NTCPK340R mutant showed reduced ubiquitination, indicating K340 as the main ubiquitination target. Furthermore, NTCPK340R had increased membrane abundance, which coincided with enhanced bile salt uptake (28.2 ± 5.3 vs. 74.4 ± 5.8 pmol; p <0.0001). Compared with NTCPWT, NTCPK340R endocytosis was strongly impaired (100 ± 47 vs. 42 ± 19%; p = 0.0079), whereas HBV-derived myr-preS1 peptide binding was increased (100 ± 33 vs. 220 ± 98%; p <0.0001). Compared with NTCPWT cells, HBV DNA content was strongly reduced in NTCPK340R cells (52.74 ± 26.23 vs. 7.22 ± 3.28%; p = 0.0022). In line with this, TAK-243 reduced cellular ubiquitination levels and increased bile salt uptake (48.65 ± 2.27 vs. 105.8 ± 4.12 pmol; p = 0.0286), while reducing HBV DNA content in HepG2 (100 ± 44 vs. 18 ± 13%; p <0.0001) and HepaRG cells (100 ± 24 vs. 65 ± 6%; p = 0.0483).

K340 is essential for NTCP ubiquitination. Inhibiting ubiquitination impaired NTCP endocytosis and reduced HBV infection, confirming that NTCP-mediated endocytosis is critical for HBV hepatic entry.

This study contributes to elucidating the process of how HBV enters hepatocytes, which is largely elusive. NTCP was found not only to be required for the binding of HBV to hepatocytes, but also to have a crucial role in hepatic internalization of HBV. In addition, a K at position 340 was identified as the main ubiquitination target of NTCP; ubiquitination-mediated endocytosis of NTCP at this position is likely to be the mechanism regulating HBV internalization. Thus, interfering with NTCP ubiquitination could provide a novel means to reduce HBV infection.

Image 1

•K340 is likely to be the main ubiquitination target within NTCP.•Mutating K340 to arginine increased NTCP protein levels and bile salt uptake.•Mutating K340 to arginine reduced NTCP endocytosis and HBV infection.•Inhibition of protein ubiquitination with TAK-243 inhibited HBV infection.•K340 is crucial for HBV entry as a result of ubiquitin-mediated NTCP endocytosis.

K340 is likely to be the main ubiquitination target within NTCP.

Mutating K340 to arginine increased NTCP protein levels and bile salt uptake.

Mutating K340 to arginine reduced NTCP endocytosis and HBV infection.

Inhibition of protein ubiquitination with TAK-243 inhibited HBV infection.

K340 is crucial for HBV entry as a result of ubiquitin-mediated NTCP endocytosis.